Unexpectedly, our retrospective analysis of the SFTS cohort revealed not only elevated hepatic inflammation markers (ALT, AST) as previously documented, but also significantly increased amylase and lipase levels—indicators of pancreatitis. The gene discussed is GPT; the disease is pancreatitis.